Related Experiment Video
Updated: Aug 9, 2026

12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Prognosis in amyotrophic lateral sclerosis: a population-based study
M A del Aguila1, W T Longstreth, V McGuire
1Department of Dental Public Health Sciences, University of Washington, Seattle, USA.
Neurology
|March 12, 2003
Summary
Accurate Amyotrophic Lateral Sclerosis (ALS) prognosis is crucial. Key factors predicting survival include older age, female sex, bulbar onset, and lack of a partner, highlighting the disease's severity.
Area of Science:
- Neurology
- Epidemiology
- Clinical Research
Background:
- Prognostic information for Amyotrophic Lateral Sclerosis (ALS) is vital for patients, families, and healthcare providers.
- Understanding ALS progression aids in patient care and management.
Purpose of the Study:
- To identify key prognostic factors for Amyotrophic Lateral Sclerosis (ALS).
- To provide accurate survival data for ALS patients.
Main Methods:
- A population-based cohort study of 180 incident Amyotrophic Lateral Sclerosis (ALS) patients (1990-1994) in western Washington.
- Data collection included in-person interviews for prognostic factors and SF-36 health surveys.
- Vital status was tracked through December 1999.
Main Results:
- Median survival was 32 months from symptom onset and 19 months from diagnosis; 5-year survival was 7%.
- Poor prognostic indicators included older age, female sex, bulbar features at onset, shorter time to diagnosis, and lack of a marital partner.
- Better physical health scores on the SF-36 correlated with longer survival.
Conclusions:
- Findings confirm the aggressive nature of ALS and identify critical prognostic factors.
- Key predictors of survival are age, sex, bulbar onset, time to diagnosis, marital status, and disease severity.
- Regular assessment of disease severity could enhance prognostic accuracy.
Related Concept Videos
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

